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Abstract
Purpose Interatrial block (IAB) frequently coexists with sinus
node disease and is considered a risk factor of left atrial
dysfunction, atrial arrhythmias, and heart failure development.
Conventional right atrial appendage (RAA) pacing impairs
intra- and interatrial conductions and consequently prolongs P
wave duration. Biatrial (BiA) pacing helps correct IAB, but its
advantageous influence remains controversial. The aim of the
study was to compare the effects of BiA and RAA pacing on
cardiac hemodynamics and serum concentrations of inflam-
matory markers and neuropeptides.
Methods Twenty-eight patients with IAB and preserved atrio-
ventricular conduction treated with BiA pacing were studied.
Standard invasive hemodynamic measurements were
performed during BiA and RAA pacings. Furthermore, the
influence of 1 week of BiA and RAA pacing on neuropep-
tides: atrial natriuretic peptide (ANP) and brain natriuretic
peptide (BNP) and markers of inflammation: high sensitivity
C-reactive protein (hs-CRP), interleukin 6 (IL-6), and
neopterin was examined.
Results BiA pacing resulted in significant increase of cardi-
ac output (CO) and reduction of pulmonary capillary wedge
pressure. We demonstrated significantly lower concentra-
tions of ANP, hs-CRP, IL-6, and neopterin after 1 week of
BiA in comparison to RAA pacing. BNP levels remained
unchanged.
Conclusions BiA pacing in comparison to RAA pacing im-
proves hemodynamic performance in patients with IAB and
preserved atrio-ventricular conduction. BiA pacing is associ-
ated with reduction of ANP and markers of inflammation
(hs-CRP, IL-6, and neopterin).
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1 Background
Interatrial block (IAB) is defined as impaired conduc-
tion between right and left atrium (LA) and is reflected
by prolonged P wave duration exceeding 120 ms on the
surface ECG. IAB can be identified in up to 40–50 %
of routinely performed ECGs but is frequently
overlooked or ignored [1, 2]. IAB is associated with
atrial electromechanical dysfunction, which in conjunc-
tion with delayed LA contraction in relation to left
ventricular (LV) contraction, may reduce cardiac output
[3, 4]. In patients with atrio-ventricular (A-V) block,
IAB might be partially balanced, restoring the timing in the
left heart. However, IAB does not always coexist with A-V
conduction prolongation.
Right atrial appendage (RAA) is still the conventional
location of atrial lead. Nonetheless, it has been demonstrated
that RAA pacing may induce or exacerbate intra- and
interatrial conduction disturbances [5, 6]. Biatrial (BiA)
pacing is one of the methods of reducing IAB and decreas-
ing the incidence of atrial tachyarrhythmias [7–9]. With
respect to cardiac hemodynamics, however, the superiority
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of BiA over standard RAA pacing remains controversial as
data from available studies are conflicting [10–14].
The aim of the present study was two-fold. Firstly, we
aimed to investigate whether patients with IAB and intact A-
V conduction (i.e., patients without the balancing effect of
prolonged A-V conduction) could benefit from BiA in com-
parison to RAA pacing in terms of hemodynamic perfor-
mance. Secondly, we aimed to determine the influence of
both pacing modes on prognostic markers: atrial natriuretic
peptide (ANP), brain natriuretic peptide (BNP), high sensi-
tivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), and
neopterin.
2 Material and methods
The study was conducted in patients with BiA pacemakers
implanted as a standard practice in our center in the course of
1 year due to sinus node dysfunction, documented symptom-
atic recurrent atrial fibrillation (AF), signs of advanced intra-
and interatrial conduction delay, and with indications for
routine coronary angiography according to current European
Society of Cardiology guidelines. Inclusion criteria were de-
fined as follows: P-wave duration ≥120 ms during sinus
rhythm, preserved A-V conduction (PQ interval ≤200 ms),
and more than 85 % of pacing during 4 weeks before inclu-
sion. Exclusion criteria included the following: structural heart
disease, AF requiring cardioversion within 4 weeks before and
throughout the study, symptomatic heart failure (HF) New
York Heart Association (NYHA) class III or higher, active
infections, history of malignancies and connective tissue dis-
eases, anti-inflammatory/immunosuppressive treatment, and
acute coronary syndrome within 3 months before enrolment.
All patients with any AF episode during the hemodynamic
assessment were excluded from the study. Patients were ex-
cluded from the biochemical part of the study if AF lasted
longer than 24 h or required cardioversion.
Initially, 34 patients fulfilled inclusion criteria, 6 of whom
were excluded from analysis due to infection (1) and AF
recurrences (5). The study protocol was approved by the
Ethics Committee of The Medical University of Lublin,
Poland and followed the guidelines of the Declaration of
Helsinki. Each participant gave written informed consent
accepting the study protocol (Fig. 1).
2.1 Pacemaker implantation
All patients had BiA pacing system utilizing standard dual
chamber pacemaker (Axios DR or Philos DR, Biotronik
GmbH, Germany) implanted at least 6 weeks (6 to 45 weeks,
median 8 weeks) before enrolment. Atrial channel was
connected to the lead positioned in RAA and ventricular
channel to the lead implanted in mid/distal coronary sinus
(CS) (Corox LA-H, Biotronik GmbH, Germany, bipolar,
passive fixation). During BiA pacing, an A-V delay was
set to 15 ms. In order to ensure stable atrial pacing, the basic
rate was programmed at least 10 bpm above intrinsic sinus
rate (AAI mode) to keep baseline heart rate 60–75 bpm
(depending on baseline bradycardia) and was constant
throughout the study. In each patient, 100 % pacing was
ensured during echocardiographic and hemodynamic stud-
ies and at least 85 % during biochemical study. At the
beginning of the study and each time the pacemaker was
reprogrammed, the RAA and CS thresholds were checked,
and the pacing impulse amplitude was programmed at least
twice the measured pacing threshold. ECG tracings were
printed after each reprogramming to confirm pacing mode
and capture. Investigators who performed hemodynamic
and echocardiographic measurements and laboratory tests
were blinded to the pacing mode.
2.2 Hemodynamic study
Standard invasive hemodynamic measurements were
obtained in fasting patients in supine position following rou-
tine coronary angiography. Measurements were recorded after
at least 5-min randomly assigned pacingmode—RAA or BiA.
Then, the pacingmode was switched to the other one (RAA or
BiA), and after at least 5 min, measurements were repeated.
Mid-chest position was used for the zero reference level.
Cardiac output was determined by Fick method. Pressure
curves were analyzed by two independent investigators.
2.3 Echocardiography
Echocardiography was performed following the joint guide-
lines of the European Association of Echocardiography and
the American Society of Echocardiography using commer-
cially available ultrasound system (iE33, Philips). LAvolume
was measured from standard apical two- and four-chamber
views at end-systole. LA borders were traced using
planimetry. LA volume index (LAVI) was calculated by di-
viding the LA volume by body surface area [15]. The closure
of the mitral valve was determined from the parasternal long
view using M-mode and timed to the QRS complex.
2.4 Biochemical study
Two weeks after hemodynamic measurements, the second
part of the study was conducted in the same population.
ANP, BNP, hs-CRP, IL-6, and neopterin were assayed twice:
after 7 days of BiA and 7 days of RAA pacing in randomly
assigned order (cross-over design). Blood samples were
collected in fasting patients after at least 30 min of rest in
supine position. Blood samples taken for cytokine analysis
were immediately centrifuged (4,000 rpm for 10 min at 4 °C).
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Serum was frozen and kept at −80 °C until assay.
Concentrations of hs-CRP (IBL, USA), IL-6 (R&D, UK),
and neopterin (R&D, UK) were determined with commercial-
ly available ELISA test kits in accordancewithmanufacturers’
recommendations. Samples for ANP and BNP measurements
were collected into ice-chilled tubes containing EDTA and
aprotinin, centrifuged (2,000 rpm for 20 min at 4 °C), frozen,
and stored at −80 °C until assay. ANP and BNP were assayed
with commercially available ELISA test kits (BNP: IBL,
Germany; ANP: Wuhan EIAab Science Co., Ltd).
Additionally, basic blood tests were performed. All medica-
tions were kept constant throughout the study.
2.5 Statistical analysis
Data are presented as mean ± standard deviation. Differences
between measurements were compared with Wilcoxon’s non-
parametric test. A p value <0.05 was considered statistically
significant.
3 Results
Initially, 34 patients fulfilled the inclusion criteria, 6 of
whom were excluded from analysis due to infection (1)
and AF recurrences (5). Two patients developed AF during
the hemodynamic examination and 3 during the biochemical
part of the study. All AF episodes occurred during RAA
pacing. Consequently, 28 patients were analyzed
(15 males, 13 females; mean age 66.6 years).
Baseline characteristics of the study population are sum-
marized in Table 1. Results of ECG and echocardiographic
and invasive hemodynamic measurements are presented in
Table 2. BiA pacing, in comparison to RAA pacing, resulted
in statistically significant shortening of P wave duration
(115±11 vs. 173±15 ms; p=0.0001) and PQ interval
(190±10 vs. 221±14 ms; p=0.0002).
There were pronounced differences in the transmitral
flow assessed by PW Doppler between the two pacing
modes. Intervals from atrial pacing spike on the ECG to
the onset (P-A onset), peak (P-A peak), and end (P-A end),
of the mitral atrial filling wave (A) were significantly shorter
during BiA in comparison to RAA pacing (87±11 vs. 119±
15 ms, p=0.0001; 146±11 vs. 190±17 ms, p=0.0001; 214±
16 vs. 276±15 ms, p=0.0001). Mitral inflow velocity time
integral (VTI) (12.1±2.1 vs. 9.9±2.0 cm; p=0.01) and peak
velocity of the mitral atrial wave (AVmax) (107±10 vs. 90±
11 cm/s; p=0.04) were higher during BiA pacing.
Intervals between the end of the atrial filling wave of
transmitral flow and the mitral valve closure (A end-MC) were
significantly longer during BiA in comparison to RAA pacing
(71±32 vs. 36±55 ms; p=0.001). In invasive hemodynamic
examination, we observed beneficial effects of BiA in compar-
ison to RAA pacing on cardiac hemodynamics. BiA pacing
resulted in higher cardiac output (CO) (4.9±0.8 vs. 4.1±
0.7 l/min; p=0.02) and lower pulmonary artery wedge pressure
(PCWP) (11.0±1.9 vs. 12.9±2.1 mmHg; p=0.02).
In biochemical study, we demonstrated significantly low-
er serum concentrations of ANP, hs-CRP, IL-6, and
neopterin after 1 week of BiA in comparison to RAA
pacing. Concentrations of BNP remained unchanged.
There were no differences in total blood count, serum urea,
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Fig. 1 Study protocol
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4 Discussion
RAA is the standard lead position routinely used for perma-
nent atrial pacing even in patients with coexisting interatrial
conduction abnormalities. It has been demonstrated that
RAA pacing exacerbates interatrial conduction disturbances
and has unfavorable proarrhythmic and hemodynamic con-
sequences [6]. However, it is still a matter of debate whether
BiA in comparison to standard RAA pacing could improve
hemodynamics and prognosis in individuals with IAB.
In our study, invasive hemodynamic measurements re-
vealed CO increase and PCWP reduction during BiA in
comparison to RAA pacing. Previous invasive hemodynamic
studies indicating that BiA pacing might increase CO and
decrease PCWP, when compared to high right atrium,
concerned patients with IAB and dual chamber pacing
(DDD) pacing [10, 12]. In order to elucidate the hemodynam-
ic effect of pure BiA and RAA pacing and to avoid potential
influence of A-V delay and ventricular pacing during DDD
stimulation, we focused on patients with intact A-V conduc-
tion. Levy et al. [13] and Dabrowska-Kugacka et al. [11] did
not find statistical differences in CO between RAA and BiA
pacing. However, in both studies, echocardiography was used
for LV systolic function evaluation, which obviously is less
accurate than invasive measurements. Furthermore,
populations in both studies were small and consisted of only
8 and 14 patients, respectively. Furthermore, patients with
prolonged A-V conduction and heart failure associated with
interventricular conduction abnormalities were not excluded,
which might have blunted the effect of BiA and RAA pacing
on cardiac hemodynamics [16]. The population in the study of
Levy et al. [13] consisted of patients with bradycardia–tachy-
cardia syndrome, and the interatrial conduction was not
specified. It has been already demonstrated that patients
without baseline IAB do not benefit from BiA pacing com-
pared to sinus rhythm, while RAA pacing has an unfavorable
hemodynamic effect in this group [16].
In our study, echocardiographic examination revealed
higher VTI of the mitral inflow as well as aortic VTI during
BiA vs. RAA pacing, which confirms with the observations
made by Matsumoto et al. [14]. It is known that BiA pacing
improves atrial systolic function [16–19]. More synchronous
LA segment contraction during BiA in comparison to single
site (RAA or CS) pacing might explain this observation
[17, 18]. A positive influence of BiA pacing on global systolic
LA function was observed in the stunned atrium after cardio-
version of persistent AF [20].
It has also been demonstrated that RAA pacing exacerbates
interatrial conduction disturbances leading to unfavorable he-
modynamic consequences [6]. RAA pacing was detrimental
to cardiac electromechanical function when compared to sinus
rhythm [20]. Since no measurements during sinus rhythm
were performed in our study (because of substantial brady-
cardia), we cannot rule out the possibility that what we
observed was not an advantageous effect of BiA but only a
correction of an unfavorable effect of RAA pacing.
Analysis of mitral inflow during RAA pacing revealed
that in the majority of our patients, there was no A end-MC
delay, which suggested that LV contraction interrupted atrial
filling. This effect was not observed during BiA pacing,
which prolonged left heart A-V interval.
LV activation occurs earlier during BiA in comparison to
RAA pacing, and consequently PQ interval is shortened.
However, LA is also preactivated, which results in shorter
P-A onset, P-A peak, and P-A end of the Doppler mitral A
filling wave. This prevents mitral inflow restriction by pre-
mature mitral valve closure during BiA pacing.
The effects of change in left A-V timing (PQ duration, P-A
intervals, duration of E and A waves, ventricular relaxation,
and velocity of transmitral flow (peak mitral early filling
velocity/EVmax and peak atrial filling velocity/AVmax))
should not be considered the independent benefits of BiA
pacing because they are mutually dependent and are finally
reflected in mitral and aortic VTI as well as CO. Improved CO
during BiA, in comparison to RAA pacing, may be due to
increased preload as a result of increased mitral inflow. LV
relaxation begins as an initial diastolic process, and LV
Table 1 Patient characteristics (n=28)
Number
With coronary artery disease 28
With hypertension 18




Mean left ventricular diastolic dimention (cm) 4.7±0.5
Mean right ventricular dimension (cm) 2.7±0.3
Mean ejection fraction (%) 57±4
Mean left atrial diameter (cm) 4.4±0.4
Mean P wave duration during sinus rhythm in lead II (ms) 145±13
Mean PQ interval during sinus rhythm in lead II (ms) 185±15










ACEi angiotensin converting enzyme inhibitor, ARB angiotensin re-
ceptor blocker, ASA acetylsalicylic acid, VKA vitamin K antagonist
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pressure falls rapidly as the LV expands. Myocardial relaxa-
tion continues during early diastole to reach the minimal LV
diastolic pressure, which helps with “sucking” and “pulling”
the blood actively into the LV. LV pressure then rises and the
early diastolic filling decelerates until the time of atrial con-
traction when LA pressure increases again to initiate the late
filling and to complete diastole. Mitral E inflow is sensitive to
preload. It is becoming higher with shorter deceleration time
(time from the peak to the baseline) as diastolic function
deteriorates with increasing filling pressure [21]. Relaxation
abnormalities result in the reduction in the rate of LV pressure
decline during the early diastole. Consequently, atrial contrac-
tion is responsible for a substantial proportion of diastolic
filling. In our study, there was no difference in diastolic
dysfunction indices (E/A, DTE, IVRT, LAVI) between BiA
and RAA pacing groups. Additionally, these markers were
within normal ranges. As there was no diastolic dysfunction in
the studied population, raised mitral inflow can be primarily
attributed to increased preload, resulting from optimal timing
of LA contraction and its contribution to LV filling [13, 22].




Measurements during BiA and
RAA pacings at a fixed rate were
compared (n=28)
A end-MC interval between the
end of the atrial filling wave of
transmitral flow and the mitral
valve closure, ANP atrial natri-
uretic peptide, AoPEP left ven-
tricular pre-ejection time, AoVTI
aortic velocity time integral,
AVmax peak atrial filling velocity,
BNP brain natriuretic peptide, CO
cardiac output, DTE deceleration
time of early filling velocity, LVET
left ventricular ejection time,
EVmax peak mitral early filling
velocity, hs-CRP high sensitivity
C-reactive protein, IL-6 interleu-
kin-6, IVCP inferior vena cava
pressure, IVRT isovolumetric re-
laxation time, LA left atrial area,
LAVI left atrial volume index,
mAPmean arterial pressure,mPAP
mean pulmonary artery pressure,
MR mitral regurgitation area, ns
not significant, P-A interval be-
tween the beginning of the atrial
pacing spike and the onset/peak/
end of mitral atrial filing wave,
PCWP pulmonary capillary
wedge pressure, RAP right atrial
pressure, RV ESP/EDP right ven-
tricular end-systolic/end-diastolic




BiAp RAAp p value
Hemodynamic measurements
RAP (mmHg) 5.6±2.3 6.0±2.1 ns
RV ESP (mmHg) 28.3±7.0 27.5±7.5 ns
RV EDP (mmHg) 7.4±2.5 7.8±2.8 ns
mPAP (mmHg) 18.1±4.4 17.9±4.3 ns
PCWP (mmHg) 11.0±1,9 12.9±2.1 0.02
mAP (mmHg) 106.3±12.5 104.4±12.7 ns
CO (l/min) 4.9±0.8 4.1±0.7 0.02
IVCP (mmHg) 6.5±3.5 7.1±4.1 ns
Echocardiographic measurements
VTIm (cm) 12.1±2.1 9.9±2.0 0.01
EVmax (cm/s) 96±11 87±10 ns
AVmax (cm/s) 107±10 90±11 0.04
E/A ratio 0.89±0.12 0.88±0.12 ns
DTE (ms) 170±18 175±19 ns
IVRT (ms) 94±10 97±9 ns
LA area (cm2) 24±5 24±6 ns
LAVI (ml/m2) 41±5 42.5±5.5 ns
MR area (cm2) 3.3±0.7 3.9±1.3 ns
P-A onset (ms) 87±11 119±15 0.0001
P-A peak (ms) 146±11 190±17 0.0001
P-A end (ms) 214±16 276±15 0.0001
A end-MC 71±32 36±55 0.001
AoVTI (cm) 34±5 30±8 0.02
AoPEP (ms) 108±18 105±17 ns
LVET (ms) 295±17 289±19 ns
Biochemical markers
ANP (pg/ml) 199±45 265±48 0.002
BNP (pg/ml) 122±32 142±41 ns
hs-CRP (mg/ml) 2.1±0.4 2.8±05 0.02
Neopterin (pg/ml) 11.8±3.1 14.8±3.3 0.03
IL-6 (pg/ml) 4.4±0.6 5.3±0.7 0.02
Electrocardiographic parameters
Paced P wave duration (ms) 115±11 173±15 0.0001
PQ interval (ms) 190±10 221±14 0.0002
QRS duration (ms) 91±12 92±11 ns
Mean pacing rate (bpm) 65±7 66±7 ns
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Previous researchers defined the effects of altered preload on
the indices of transmitral Doppler echocardiography [23–25].
Phasic function of LA may offer additional explanation of
the results of our study. The LA mechanical function can be
described by three phases within the cardiac cycle [26, 27].
Firstly, during ventricular systole and isovolumic relaxation, the
LA functions as a “reservoir” that receives blood from pulmo-
nary venous return and stores energy in the form of pressure.
Secondly, during the early phase of ventricular diastole, the LA
operates as a “conduit” for transfer of blood into the LV after
mitral valve opening via pressure gradient. During LV diastasis,
blood flows passively from the pulmonary veins into the LV.
Thirdly, the “contractile” function of the LA normally serves to
augment the LV stroke volume by approximately 20 % [28].
The relative contribution of this “booster pump” function be-
comes probably more dominant in the setting of BiA rather
than RAA pacing as a result of synchronous, thus more effec-
tive LA contraction. These observations are convincing in the
light of previous research, which suggested that the improve-
ment of LA contractile function, expressed as LA ejection
fraction, is possible after the reversion of atrial cardiomyopathy
developed as a consequence of AF [29].
BiA in comparison to RAA pacing significantly shortened
P wave duration and PQ interval. This observation confirms
the results of previous studies. It is well established that RAA
pacing impairs inter- and intra-atrial conduction and prolongs
PQ interval; on the other hand, BiA pacing shortens it, in
comparison to sinus rhythm [18, 20, 30, 31]. P wave shorten-
ing is obviously the result of simultaneous left and right atrial
activations. PQ interval shortening might be the effect of
quicker conduction from CS to A-V node in comparison to
conduction from RAA to A-V node [16]. Additionally, the
presence of two simultaneous depolarization wavefronts dur-
ing BiA pacing increases the possibility of going round po-
tential slow conduction areas in the atria [9, 32, 33].
In our study, BiA pacing turned out to be associated with
lower serum ANP as well as lower proinflammatory hs-CRP,
IL-6, and neopterin concentrations in comparison to RAA
pacing. Both reduced ANP levels and PCWP indicate that
mean atrial pressure and stretch are lower during BiA in
comparison to RAA pacing. This might be due to more
synchronous atrial contraction [18] and better A-V timing,
which in this case is related to the increase of interval between
the end of the atrial filling wave of transmitral flow and the
mitral valve closure. This, in turn, prevents premature closure
of the mitral valve before the completion of atrial contraction
[34]. If A-V conduction is intact, the IAB during RAA pacing
shortens the time available for LA activation, which is asso-
ciated with premature mitral closure, abbreviated LA contrac-
tion, and therefore higher LA pressures and associated ANP
levels. Lower atrial pressure and stretch during BiA pacing
could partially explain its anti-arrhythmic effect [9, 35] since
atrial stretch shortens the atrial refractory period, prolongs the
interatrial conduction time, and increases the dispersion of
refractoriness [36].
Our study is the first to report that BiA in comparison to
RAA pacing could be associated with the reduction of unfa-
vorable prognostic proinflammatory markers of HF (hs-CRP,
IL-6, and neopterin). A substantial body of evidence supports
the concept that markers of inflammation (CRP and IL-6) are
predictors of unfavorable cardiovascular events, including
heart failure development [37–40] and all-cause mortality
irrespective of cardiovascular disease [41, 42]. Moreover,
elevated levels of proinflammatory markers such as IL-6 and
CRP increase the risk of supraventricular and ventricular
cardiac arrhythmias and their complications [43, 44].
One may, therefore, hypothesize that permanent BiA pac-
ing, in comparison to RAA, might be associated with better
prognosis. The National Health and Nutrition Examination
Survey revealed significant correlation between P wave dura-
tion and increased cardiovascular and all-cause mortality [45].
In our study, P wave duration during BiA pacing was signif-
icantly shortened in comparison to RAA pacing, which seems
consistent with changes in concentrations of proinflammatory
markers. However, the issue requires further research to con-
firm whether this “anti-inflammatory” effect persists in longer
observation.
4.1 Study limitations
The studied population is relatively small, and the variabil-
ity of measured parameters is quite considerable. During the
time, between pacemaker implantation and the experiment,
patients were programmed to BiA pacing, which might have
contributed to remodeling. We believe that even if a subtle
remodeling occurred, it had no substantial effect on the
study results. One should also be aware of the carry-over
effect of the preceding pacing mode in the cross-over design
during echocardiographic, hemodynamic and biochemical
studies. We intended to lessen this effect by applying rela-
tively long periods between measurements. For the cytokine
assessment, each pacing mode was programmed for 7 days
and therefore should not be extrapolated to represent the
effect of chronic pacing. Five patients developed AF during
RAA pacing, and those patients were excluded from the
study to avoid effects of AF on atrial function, natriuretic
peptides, and cytokines. If we assume that AF during RAA
pacing was caused by escalated left A-V dyssynchrony, the
exclusion of these patients might have diminished the stud-
ied effect. Different heart rates between subjects contributed
to parameter variability and theoretically may have contrib-
uted to the differences in the findings. Finally, the influence
of Doppler measurement reproducibility cannot be exclud-
ed. The reproducibility of Doppler measurements in our
echo laboratory was 95 %, which we believe had no signif-
icant effect on the overall results of our study.
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5 Conclusions
BiA pacing, in comparison to RAA pacing, acutely im-
proves hemodynamic performance in patients with IAB
and preserved A-V conduction and is associated with the
reduction of ANP and markers of inflammation (hs-CRP,
IL-6, and neopterin). Therefore, we provide an additional
argument for considering BiA, instead of standard RAA
pacing, which could improve cardiac hemodynamics and
may influence prognosis in patients with IAB and preserved
A-V conduction. Still, we believe that the results should be
confirmed in a larger cohort of patients.
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